HighTower Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $426K | Sell |
117,100
-9,000
| -7% | -$32.8K | ﹤0.01% | 2654 |
|
2025
Q1 | $242K | Buy |
126,100
+32,750
| +35% | +$62.9K | ﹤0.01% | 3017 |
|
2024
Q4 | $177K | Hold |
93,350
| – | – | ﹤0.01% | 3204 |
|
2024
Q3 | $122K | Buy |
93,350
+5,000
| +6% | +$6.54K | ﹤0.01% | 3243 |
|
2024
Q2 | $89K | Buy |
88,350
+15,000
| +20% | +$15.1K | ﹤0.01% | 3189 |
|
2024
Q1 | $135K | Sell |
73,350
-23,000
| -24% | -$42.3K | ﹤0.01% | 3056 |
|
2023
Q4 | $119K | Buy |
96,350
+1,000
| +1% | +$1.24K | ﹤0.01% | 3123 |
|
2023
Q3 | $109K | Buy |
95,350
+25,000
| +36% | +$28.6K | ﹤0.01% | 3059 |
|
2023
Q2 | $65K | Hold |
70,350
| – | – | ﹤0.01% | 3100 |
|
2023
Q1 | $40K | Buy |
70,350
+10,925
| +18% | +$6.21K | ﹤0.01% | 3013 |
|
2022
Q4 | $34K | Buy |
59,425
+7,401
| +14% | +$4.23K | ﹤0.01% | 3013 |
|
2022
Q3 | $16K | Buy |
52,024
+6,300
| +14% | +$1.94K | ﹤0.01% | 2908 |
|
2022
Q2 | $16K | Sell |
45,724
-2,958
| -6% | -$1.04K | ﹤0.01% | 2937 |
|
2022
Q1 | $35K | Sell |
48,682
-11
| -0% | -$8 | ﹤0.01% | 3038 |
|
2021
Q4 | $110K | Hold |
48,693
| – | – | ﹤0.01% | 2870 |
|
2021
Q3 | $141K | Sell |
48,693
-450
| -0.9% | -$1.3K | ﹤0.01% | 2778 |
|
2021
Q2 | $187K | Hold |
49,143
| – | – | ﹤0.01% | 2675 |
|
2021
Q1 | $167K | Sell |
49,143
-342
| -0.7% | -$1.16K | ﹤0.01% | 2638 |
|
2020
Q4 | $139K | Sell |
49,485
-2,552
| -5% | -$7.17K | ﹤0.01% | 2244 |
|
2020
Q3 | $129K | Buy |
52,037
+15,781
| +44% | +$39.1K | ﹤0.01% | 2159 |
|
2020
Q2 | $493K | Buy |
36,256
+450
| +1% | +$6.12K | ﹤0.01% | 1460 |
|
2020
Q1 | $271K | Hold |
35,806
| – | – | ﹤0.01% | 1608 |
|
2019
Q4 | $226K | Buy |
35,806
+18,875
| +111% | +$119K | ﹤0.01% | 1882 |
|
2019
Q3 | $66K | Buy |
16,931
+754
| +5% | +$2.94K | ﹤0.01% | 2182 |
|
2019
Q2 | $79K | Buy |
+16,177
| New | +$79K | ﹤0.01% | 2161 |
|